Volume | 0.00 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Viridas | VIR | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.275 | 0.275 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0.00 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | O | 0 | 0.275p | GBX |
Viridas Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0.00p | - | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Viridas News
Viridas Discussion Forums - VIR
Date | Time | Comments | Title |
---|---|---|---|
5/03/2024 | 13:14 | - | VIR 1Q24 CC transcript: |
5/03/2024 | 10:15 | - | VIR still reversing off the recent 52 week low |
5/02/2024 | 11:22 | - | VIR reports 1Q24 results—3/31/24 cash=$1.51B(!): |
4/28/2024 | 12:24 | - | VIR under $10 |
4/18/2024 | 08:25 | - | VIR adds two luminaries to BoD: |
2/23/2024 | 10:17 | - | VIR 4Q23 CC transcript: |
2/22/2024 | 12:42 | - | VIR 4Q23 CC slides: |
2/22/2024 | 12:28 | - | VIR reports 4Q23 results—issues 2024 expense guidance: |
2/22/2024 | 10:27 | - | VIR’s CMO left the company, which explains the |
2/22/2024 | 10:24 | - | GSK, VIR terminate flu collaboration inked in 2021: |
Historical VIR Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00% |